APA

Blazar B. R., Taylor P. A., Noelle R. J. & Vallera D. A. (19980826). CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses. : The Journal of clinical investigation.

Chicago

Blazar B R, Taylor P A, Noelle R J and Vallera D A. 19980826. CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses. : The Journal of clinical investigation.

Harvard

Blazar B. R., Taylor P. A., Noelle R. J. and Vallera D. A. (19980826). CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses. : The Journal of clinical investigation.

MLA

Blazar B R, Taylor P A, Noelle R J and Vallera D A. CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses. : The Journal of clinical investigation. 19980826.